CD274 and neoplasm: Collectively, these molecular and microenvironmental factors influence PD-L1 expression in tumors, potentially leading to false positive cases where high PD-L1 expression does not reflect a tumor’s T cell infiltration and actual susceptibility to checkpoint inhibitors (Figure 1).